MX2021000023A - Composicion y metodo para el ahorro de opioides. - Google Patents

Composicion y metodo para el ahorro de opioides.

Info

Publication number
MX2021000023A
MX2021000023A MX2021000023A MX2021000023A MX2021000023A MX 2021000023 A MX2021000023 A MX 2021000023A MX 2021000023 A MX2021000023 A MX 2021000023A MX 2021000023 A MX2021000023 A MX 2021000023A MX 2021000023 A MX2021000023 A MX 2021000023A
Authority
MX
Mexico
Prior art keywords
composition
opioid
opioid sparing
sparing
sup
Prior art date
Application number
MX2021000023A
Other languages
English (en)
Inventor
Harry Karelis
Original Assignee
Zelira Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zelira Therapeutics Operations Pty Ltd filed Critical Zelira Therapeutics Operations Pty Ltd
Publication of MX2021000023A publication Critical patent/MX2021000023A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se relación con una composición farmacéutica que comprende ?9-tetrahidrocannabinol (THC), cannabidiol (CBD) y una fracción de terpenos obtenida por extracción de una planta de Cannabis y su uso en el tratamiento de la dependencia y/o adicción a los opioides. La invención también se refiere a métodos para el ahorro de opioides.
MX2021000023A 2018-07-03 2019-07-03 Composicion y metodo para el ahorro de opioides. MX2021000023A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018100928A AU2018100928A4 (en) 2018-07-03 2018-07-03 Composition and method for opioid sparing
PCT/AU2019/050699 WO2020006598A1 (en) 2018-07-03 2019-07-03 Composition and method for opioid sparing

Publications (1)

Publication Number Publication Date
MX2021000023A true MX2021000023A (es) 2021-05-27

Family

ID=63079660

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000023A MX2021000023A (es) 2018-07-03 2019-07-03 Composicion y metodo para el ahorro de opioides.

Country Status (13)

Country Link
US (1) US20210290592A1 (es)
EP (1) EP3817734A4 (es)
KR (1) KR20210071941A (es)
AU (2) AU2018100928A4 (es)
BR (1) BR112020027070A2 (es)
CA (1) CA3104741A1 (es)
CL (1) CL2020003373A1 (es)
CO (1) CO2021001057A2 (es)
IL (1) IL279903A (es)
MX (1) MX2021000023A (es)
PE (1) PE20211586A1 (es)
SG (1) SG11202013194VA (es)
WO (1) WO2020006598A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020188361A1 (en) * 2019-03-21 2020-09-24 ZYUS Life Sciences US Ltd. Cannabinoid and application supported opioid tapering
JP2023529476A (ja) * 2020-06-12 2023-07-10 ゼリラ セラピューティクス オペレーションズ ピーティーワイ リミテッド 慢性疼痛を治療するための組成物及び方法
EP4362936A1 (en) * 2021-07-01 2024-05-08 Ananda Scientififc, Inc. Methods for treatment of pain with cannabinoids
WO2023144340A1 (en) 2022-01-28 2023-08-03 Vertanical GmbH Method for the production of a plant extract
WO2023144420A1 (en) 2022-01-31 2023-08-03 Vertanical GmbH Composition comprising delta-9-tetrahydrocannabinol and terpenes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3209312A1 (en) * 2014-10-21 2017-08-30 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
EP3247402A4 (en) * 2015-01-21 2018-08-08 Willinsky, Michael Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler
CA3065167A1 (en) * 2017-05-31 2018-12-06 Phytecs, Inc. Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
EP3703672A4 (en) * 2017-10-30 2021-12-01 Endocanna Health, Inc. CANNABINOID FORMULATIONS

Also Published As

Publication number Publication date
BR112020027070A2 (pt) 2021-03-30
KR20210071941A (ko) 2021-06-16
IL279903A (en) 2021-03-01
SG11202013194VA (en) 2021-01-28
PE20211586A1 (es) 2021-08-18
EP3817734A4 (en) 2022-03-16
AU2018100928A4 (en) 2018-08-09
WO2020006598A1 (en) 2020-01-09
CA3104741A1 (en) 2020-01-09
EP3817734A1 (en) 2021-05-12
US20210290592A1 (en) 2021-09-23
AU2019297197A1 (en) 2021-01-28
CL2020003373A1 (es) 2021-08-13
CO2021001057A2 (es) 2021-06-30

Similar Documents

Publication Publication Date Title
MX2021000020A (es) Composicion y metodo para tratar el dolor.
MX2021000023A (es) Composicion y metodo para el ahorro de opioides.
MX2017014195A (es) Hidrogenacion de aceite de cannabis.
MX2019001286A (es) Composicion de cannabis.
PH12018501226A1 (en) Methods for treating huntingtons disease
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
MX2023007033A (es) Extractos de cannabis y metodos de preparacion y uso de la misma.
AU2016261707A8 (en) Use of cannabis to treat fibromyalgia, methods and compositions thereof
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
MX2020001443A (es) Sistema y métodos de extracción fitoquímica para extraer fitoquímicos de plantas incluidas las plantas de la familia cannabaceae sensu stricto.
AU2017265937A1 (en) Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases
NZ734714A (en) Methods of purifying cannabinoids, compositions and kits thereof
MX2019002198A (es) Composiciones solubles en agua que comprenden cannabinoides purificadas.
NZ723838A (en) Cannabinoid compositions and uses
MX2019001285A (es) Composicion de cannabis.
EA201691808A8 (ru) Кортикостероидные композиции для местного применения
MX2017006545A (es) Proceso para la preparacion de 1-(2,6,6-trimetilciclohexil)-alcan- 3-oles.
MX2020012347A (es) Inhibidor que contiene derivado triciclico, metodo de preparacion del mismo y aplicacion del mismo.
PH12019500198A1 (en) Compounds and compositions and uses thereof
MX2021000024A (es) Composicion de cannabinoides y metodo para tratar el ptsd y/o la ansiedad.
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
MY193613A (en) Synergistic composition for osteoarthritis
MX2022007720A (es) Extractos enriquecidos con compuestos polifenolicos y metodos relacionados.
MY160160A (en) Anti-wart pharmaceutical composition and method for treating wart
MX2019015005A (es) Proceso para la preparación de composición estandarizada de arjunglucósido de la corteza de terminalia arjuna.